欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Gloeobacter violaceus 50S ribosomal protein L28 (rpmB) CSB-YP752403GCI
CSB-EP752403GCI
CSB-BP752403GCI
CSB-MP752403GCI
CSB-EP752403GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus UDP-N-acetylmuramoylalanine--D-glutamate ligase (murD) CSB-YP752404GCI
CSB-EP752404GCI
CSB-BP752404GCI
CSB-MP752404GCI
CSB-EP752404GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus UvrABC system protein C (uvrC), partial CSB-YP752405GCI
CSB-EP752405GCI
CSB-BP752405GCI
CSB-MP752405GCI
CSB-EP752405GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus 50S ribosomal protein L17 (rplQ) CSB-YP752406GCI
CSB-EP752406GCI
CSB-BP752406GCI
CSB-MP752406GCI
CSB-EP752406GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Lipoyl synthase 2 (lipA2) CSB-YP752407GCI
CSB-EP752407GCI
CSB-BP752407GCI
CSB-MP752407GCI
CSB-EP752407GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Photosystem I reaction center subunit IV (psaE) CSB-YP752408GCI
CSB-EP752408GCI
CSB-BP752408GCI
CSB-MP752408GCI
CSB-EP752408GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus L-lactate dehydrogenase (ldh) CSB-YP752409GCI
CSB-EP752409GCI
CSB-BP752409GCI
CSB-MP752409GCI
CSB-EP752409GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Adenylosuccinate synthetase (purA) CSB-YP752410GCI
CSB-EP752410GCI
CSB-BP752410GCI
CSB-MP752410GCI
CSB-EP752410GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Photosystem Q (B) protein 3 (psbA4), partial CSB-YP752411GCI1
CSB-EP752411GCI1
CSB-BP752411GCI1
CSB-MP752411GCI1
CSB-EP752411GCI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Probable cytosol aminopeptidase (pepA), partial CSB-YP752412GCI
CSB-EP752412GCI
CSB-BP752412GCI
CSB-MP752412GCI
CSB-EP752412GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Malate dehydrogenase (mdh) CSB-YP752413GCI
CSB-EP752413GCI
CSB-BP752413GCI
CSB-MP752413GCI
CSB-EP752413GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus DNA replication and repair protein recF (recF) CSB-YP752414GCI
CSB-EP752414GCI
CSB-BP752414GCI
CSB-MP752414GCI
CSB-EP752414GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B (gatB), partial CSB-YP752415GCI
CSB-EP752415GCI
CSB-BP752415GCI
CSB-MP752415GCI
CSB-EP752415GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP752416GCI
CSB-EP752416GCI
CSB-BP752416GCI
CSB-MP752416GCI
CSB-EP752416GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Peptide deformylase 2 (def2) CSB-YP752417GCI
CSB-EP752417GCI
CSB-BP752417GCI
CSB-MP752417GCI
CSB-EP752417GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus FO synthase subunit 1 (cofG) CSB-YP752418GCI
CSB-EP752418GCI
CSB-BP752418GCI
CSB-MP752418GCI
CSB-EP752418GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Probable septum site-determining protein MinC (minC) CSB-YP752419GCI
CSB-EP752419GCI
CSB-BP752419GCI
CSB-MP752419GCI
CSB-EP752419GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Putative membrane protein insertion efficiency factor (gsl1913) CSB-YP752420GCI
CSB-EP752420GCI
CSB-BP752420GCI
CSB-MP752420GCI
CSB-EP752420GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Methionyl-tRNA formyltransferase (fmt) CSB-YP752421GCI
CSB-EP752421GCI
CSB-BP752421GCI
CSB-MP752421GCI
CSB-EP752421GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Release factor glutamine methyltransferase (prmC) CSB-YP752422GCI
CSB-EP752422GCI
CSB-BP752422GCI
CSB-MP752422GCI
CSB-EP752422GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×